Protalix BioTherapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Protalix BioTherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Protalix BioTherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 73.5M shares, a 2.74% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 73.5M +1.96M +2.74% Aug 1, 2024 10-Q 2024-08-14
Q1 2024 73.1M +7.64M +11.7% Mar 1, 2024 10-K 2024-03-14
Q3 2023 73M +22.3M +44% Nov 1, 2023 10-Q 2023-11-06
Q2 2023 71.6M +21.8M +43.9% Aug 1, 2023 10-Q 2023-08-07
Q1 2023 65.4M +19.1M +41.2% Apr 30, 2023 10-Q 2023-05-04
Q3 2022 50.7M +5.11M +11.2% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 49.8M +4.2M +9.21% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 46.3M +933K +2.06% Mar 15, 2022 10-K 2022-03-31
Q3 2021 45.6M +12.2M +36.7% Nov 1, 2021 10-Q 2021-11-15
Q2 2021 45.6M +13.1M +40.4% Aug 1, 2021 10-Q 2021-08-16
Q1 2021 45.4M +30.5M +206% Apr 28, 2021 10-K/A 2021-04-30
Q3 2020 33.3M -115M -77.5% Oct 15, 2020 10-Q 2020-10-29
Q2 2020 32.4M -116M -78.1% Aug 1, 2020 10-Q 2020-08-10
Q1 2020 14.8M -134M -90% Mar 1, 2020 10-K 2020-03-12
Q3 2019 148M +7.38K +0.01% Nov 1, 2019 10-Q 2019-11-07
Q2 2019 148M +199K +0.13% Aug 1, 2019 10-Q 2019-08-08
Q1 2019 148M +2.81M +1.93% Mar 1, 2019 10-K 2019-03-18
Q3 2018 148M +8.65M +6.19% Nov 1, 2018 10-Q/A 2019-03-18
Q2 2018 148M +14.8M +11.1% Aug 1, 2018 10-Q/A 2019-03-18
Q1 2018 146M +21.4M +17.3% Mar 1, 2018 10-K 2018-03-06
Q3 2017 140M +39.8M +39.8% Nov 1, 2017 10-Q 2017-11-08
Q2 2017 133M +33.5M +33.6% Aug 1, 2017 10-Q 2017-08-09
Q1 2017 124M +24.3M +24.4% Mar 1, 2017 10-K 2017-03-16
Q3 2016 99.9M +130K +0.13% Nov 1, 2016 10-Q 2016-11-09
Q2 2016 99.8M +5.66M +6.01% Aug 1, 2016 10-Q 2016-08-08
Q1 2016 99.8M +6.2M +6.63% Mar 1, 2016 10-K 2016-03-08
Q3 2015 99.8M +6.13M +6.54% Nov 1, 2015 10-Q 2015-11-09
Q2 2015 94.2M +486K +0.52% Aug 1, 2015 10-Q 2015-08-10
Q1 2015 93.6M +23.4K +0.03% Mar 1, 2015 10-K 2015-03-12
Q3 2014 93.7M +111K +0.12% Nov 1, 2014 10-Q 2014-11-10
Q2 2014 93.7M +128K +0.14% Aug 1, 2014 10-Q 2014-08-07
Q1 2014 93.6M +77.2K +0.08% Mar 1, 2014 10-K 2014-03-13
Q3 2013 93.6M +96.6K +0.1% Nov 1, 2013 10-Q 2013-11-07
Q2 2013 93.5M +1.61M +1.76% Aug 1, 2013 10-Q 2013-08-08
Q1 2013 93.5M +1.61M +1.75% May 1, 2013 10-Q 2013-05-09
Q3 2012 93.5M +7.84M +9.16% Nov 4, 2012 10-Q 2012-11-07
Q2 2012 91.9M +6.34M +7.41% Jul 30, 2012 10-Q 2012-08-03
Q1 2012 91.9M May 3, 2012 10-Q 2012-05-09
Q3 2011 85.6M Nov 1, 2011 10-Q 2011-11-07
Q2 2011 85.6M Aug 1, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.